Related Experiment Videos
Prognostic significance in malignant melanoma of nuclear DNA content measured by a microfluorimetric method
1Department of Dermatology, University of Tsukuba, Ibaraki, Japan.
Abstract:
The nuclear DNA content of 47 primary malignant melanomas was measured by 4',6-diamidino-2-phenylindole-DNA (DAPI-DNA) microfluorimetry, and the DNA index, a quantitative measure of nuclear DNA content, was calculated. The DNA index and other clinical and pathological variables were examined and compared with patient survival using univariate and multivariate analyses. The Kaplan-Meier life table method revealed that the DNA index and metastases to regional lymph nodes significantly correlated with patient survival. A Cox proportional hazards multivariate analysis demonstrated that the DNA index, which was not significantly correlated with other variables, was the most reliable and independent factor for predicting patient survival.
Insights
The DNA index, a measure of nuclear DNA content, is a reliable predictor of malignant melanoma patient survival. This finding was independent of other clinical factors, highlighting its importance in prognosis.
Area of Science:
- Oncology
- Genetics
- Biochemistry
Background:
- Malignant melanoma prognosis relies on various clinical and pathological factors.
- Accurate prediction of patient survival is crucial for effective treatment planning.
Purpose of the Study:
- To evaluate the nuclear DNA content in primary malignant melanomas.
- To determine the prognostic value of the DNA index for patient survival.
Main Methods:
- Quantitative measurement of nuclear DNA content using 4',6-diamidino-2-phenylindole-DNA (DAPI-DNA) microfluorimetry.
- Calculation of the DNA index for 47 primary malignant melanoma samples.
- Univariate and multivariate analyses, including Kaplan-Meier and Cox proportional hazards models, were used to compare survival data with clinical and pathological variables.
Main Results:
- The DNA index significantly correlated with patient survival.
- Metastases to regional lymph nodes also showed a significant correlation with survival.
- The DNA index emerged as the most reliable and independent prognostic factor, independent of other variables.
Conclusions:
- The DNA index is a powerful and independent predictor of survival in malignant melanoma patients.
- Incorporating DNA index measurements into prognostic assessments can improve patient outcome predictions.
- Further research may explore the biological mechanisms underlying the DNA index's prognostic significance.